Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Lisa, Rollins"'
Autor:
Lucy Parker Barnes, Yara Abu Hussein, Ryan Alexander, Kileen Barry, Monica Behera, Effy Chambers, Samuel Chase, Leslie Delaney, Vanessa Filmonor, Robert Giansante, Jamie Kassa, Lily Kairis, Emily Kimmerlman, Laura Leslie, Jesse Linneman, Maeve Kirby, Noel McKillip, Carolyn Powell, Lisa Rollins, Courtney Rowley, Lydia Rhodes, Lisa Sams, Chris Sharff, Emma Wright
Publikováno v:
Journal of Technology in Counselor Education and Supervision. 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9069150e1937cd5e4215f39e0f950a0d
https://doi.org/10.22371/tces/0018
https://doi.org/10.22371/tces/0018
Autor:
Bilal Omer, Tamara Tripic, Adrian P. Gee, Carlos A. Ramos, Olga Dakhova, Hao Liu, Margaret Gilbert, Manasa Hiregange, Barbara Savoldo, Helen E. Heslop, Mina Al-Sabbagh, Swati Naik, Iulia Diaconu, Elizabeth Pacheco, Malcolm K. Brenner, April G. Durett, Conrad Russel Cruz, Gianpietro Dotti, Lisa Rollins, Robert A. Krance, Darshana Raghavan, Melissa Gates, Natalia Lapteva, Keli Sharpe, Aaron Orozco, Rayne H. Rouce, Cliona M. Rooney
Publikováno v:
Clin Cancer Res
Purpose: Current protocols for CD19 chimeric antigen receptor–expressing T cells (CD19.CAR-T cells) require recipients to tolerate preinfusion cytoreductive chemotherapy, and the presence of sufficient target antigen on normal or malignant B cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::840635a584750dbf0a5f39f13904981e
https://doi.org/10.1158/1078-0432.ccr-18-3199
https://doi.org/10.1158/1078-0432.ccr-18-3199
Autor:
Xiao-Tong Song, Kevin Evel-Kabler, Lisa Rollins, Melissa Aldrich, Feng Gao, Xue F Huang, Si-Yi Chen
Publikováno v:
PLoS Medicine, Vol 3, Iss 1, p e11 (2006)
Current efforts to develop HIV vaccines that seek to stimulate immune responses have been disappointing, underscoring the inability of natural immune responses to control HIV-1 infection. Here we tested an alternative strategy to induce anti-HIV immu
Externí odkaz:
https://doaj.org/article/7c915cb0225041ad89a8055a29a93f9b
Autor:
Petra Reinke, Lisa Rollins, Michael Schmueck-Henneresse, Natalia Lapteva, Sandhya Sharma, Gianpietro Dotti, Thomas Shum, Maksim Mamonkin, Bilal Omer, Haruko Tashiro, Cliona M. Rooney, Hans-Dieter Volk
Publikováno v:
The Journal of Immunology. 199:348-362
The outcome of therapy with chimeric Ag receptor (CAR)-modified T cells is strongly influenced by the subset origin of the infused T cells. However, because polyclonally activated T cells acquire a largely CD45RO+CCR7− effector memory phenotype aft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::332e11676540936fac0dc66351fe523f
https://doi.org/10.4049/jimmunol.1601494
https://doi.org/10.4049/jimmunol.1601494
Autor:
Zhiyong Yu, Botao Li, Jian-Lin Chen, Jiangwei Hu, Lisa Rollins, Chen Xu, Hong-Mei Ning, Lindsey Jones, Xiao-Tong Song, Xue F. Huang, Liangding Hu, Xiao Lou, Guoliang Ding, Min Jiang, Fan Yang, Bangxing Hong, Si-Yi Chen, Hu Chen, Haiyan Gao, Bin Zhang, Yuhang Li, Danhong Wang, Lianming Liao
Publikováno v:
JCI Insight
BACKGROUND. DC-based tumor vaccines have had limited clinical success thus far. SOCS1, a key inhibitor of inflammatory cytokine signaling, is an immune checkpoint regulator that limits DC immunopotency. METHODS. We generated a genetically modified DC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d5cafa16b561ba135fd56299b4046e8
https://pubmed.ncbi.nlm.nih.gov/29415891
https://pubmed.ncbi.nlm.nih.gov/29415891
Publikováno v:
Natural Killer Cells ISBN: 9781493936823
Recent advances in methods for the ex vivo expansion of human natural killer (NK) cells have facilitated the use of these powerful immune cells in clinical protocols. Further, the ability to genetically modify primary human NK cells following rapid e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab1fc59de8c48dd1f29bf9c5a908d1f3
https://doi.org/10.1007/978-1-4939-3684-7_16
https://doi.org/10.1007/978-1-4939-3684-7_16
Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
Autor:
Susann Szmania, Juan F. Vera, Dario Campana, Natalia Lapteva, Elaine Coustan-Smith, April G. Durett, Amberly Moreno-Bost, Minhtran C. Ngo, Jiali Sun, Leslie L. Huye, Adrian P. Gee, Jun Ando, Lisa Rollins, Frits Vanrhee, Cliona M. Rooney, Jian Fang, Zhuyong Mei, Tarun K. Garg, Varada Dandekar, Kimberley Jackson
Publikováno v:
Cytotherapy. 14:1131-1143
Interest in natural killer (NK) cell-based immunotherapy has resurged since new protocols for the purification and expansion of large numbers of clinical-grade cells have become available.We have successfully adapted a previously described NK expansi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee7f76f3c0b4608cbc05773776cd59f5
https://doi.org/10.3109/14653249.2012.700767
https://doi.org/10.3109/14653249.2012.700767
Autor:
Nabil Ahmed, Lisa Rollins, Gianpietro Dotti, Vita S. Salsman, Yozo Nakazawa, Leslie E. Huye, Cliona M. Rooney, Stephen Gottschalk, Ann M. Leen, Matthew H. Wilson
Publikováno v:
Molecular Therapy. 19(12):2133-2143
Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes (CTLs) can be modified to function as heterologous tumor directed effector cells that survive longer in vivo than tumor directed T cells without virus specificity, due to chronic stimulation b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3cca9433bd26be67cdd5d5dd323732d
Publikováno v:
Journal of Clinical Investigation. 121:739-751
Both mucosal and systemic immune responses are required for preventing or containing HIV transmission and chronic infection. However, currently described vaccination approaches are largely ineffective in inducing both mucosal and systemic responses.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaa97dab4913ab037a3d8215cfe7e791
https://doi.org/10.1172/jci42656
https://doi.org/10.1172/jci42656
Autor:
Si-Yi Chen, Wenhong Ren, Lisa Rollins, Natalia Lapteva, Xue F. Huang, Tatiana Goltsova, Melissa B. Aldrich
Publikováno v:
Molecular Therapy. 17:1626-1636
Tumor cells harbor unique genetic mutations, which lead to the generation of immunologically foreign antigenic peptide repertoire with the potential to induce individual tumor-specific immune responses. Here, we developed an in situ tumor vaccine wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2499c1c981226e32e72ad5f7cdc23b57
https://doi.org/10.1038/mt.2009.111
https://doi.org/10.1038/mt.2009.111